News & Press Releases

Law360 Pulse highlighted insights shared by John Koss, Head of Innovation, AI, and E-Data Consulting, during a recent panel discussion at Legalweek. The panel explored how legal teams can evaluate new technologies in the age of AI, emphasizing the importance of identifying and solving for real problems.

Sige Gutman, Life Sciences Litigation Practice Chair, was quoted in an IAM article about global patent litigation settlement in Arbutus v. Moderna surrounding COVID-19 vaccine technology.

Members Esteban Morales and Arameh O'Boyle published an article in Bloomberg Law predicting consumer class actions will increase due to evolving state and federal laws affecting telemarketing, online privacy, product labeling, and auto-renewal practices. The authors advise businesses to closely monitor these developments and strengthen arbitration clauses and class action waivers to reduce litigation risk.  

An article by Edmund Daley, Pete Michaels, and Elizabeth Platonova about a new FINRA Regulatory Notice was published by Law360. The article discusses key changes that the notice presents, including shifting a significant burden to member firms to determine when the use of negative consent is appropriate. 

Sige Gutman, Life Sciences Litigation Practice Chair, shared insights with IAM in an article about a decision by the US District Court for the District of Delaware which found that a gene therapy patent of RegenxBio and the Trustees of the University of Pennsylvania was ineligible and granted summary judgement in favor of Sarepta Therapeutics.  

Bloomberg Law featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.